CDXS Q1 2026 Earnings Surprise EPS Beat Despite Revenue Uncertainty Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress ALRM Q1 2026 Earnings EPS Beats Estimates by 54 Stock Edges Higher PubMatic PUBM Q1 2026 Earnings EPS Beats Estimates as AdTech Efficiency Drives Positive Surprise YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick GSAT Q1 2026 Earnings EPS Falls Short of Estimates Amidst Narrowing Revenue Visibility